Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS27A pseudogene 1 (RPS27AP1) is a non-coding processed pseudogene that is a sequence homolog of the functional ribosomal protein S27a gene (RPS27A). Pseudogenes are copies of genes that have lost their protein-coding ability or are otherwise no longer expressed in the cell. RPS27AP1 shares sequence similarity with RPS27A but does not produce a functional protein. While the parental gene RPS27A encodes a ubiquitin–ribosomal protein fusion important for ribosome function and protein turnover, RPS27AP1 is not known to have any direct biological function, serve as a receptor, or be targeted by therapeutic agents. Presence of this and similar pseudogenes is common in the genome, and they may serve as genetic markers or be involved in gene regulation through non-coding RNA activity, but there is no evidence that RPS27AP1 serves a direct role in disease, therapy, or normal cellular activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPS27A pseudogene 1 (RPS27AP1).